Expression and functional mechanism of high mobility group A2 in neoplasm

Abstract

LI Qing, LU Ying, ZHANG Chun-Ying, MAO Jun, LI Lian-Hong. Expression and functional mechanism of high mobility group A2 in neoplasm[J]. Journal of International Oncology, 2016, 43(2): 106-.

［1］ Zha L, Zhang J, Tang W, et al. HMGA2 elicits EMT by activating the Wnt/βcatenin pathway in gastric cancer［J］. Dig Dis Sci, 2013, 58(3): 724733. DOI:10.1007/s1062001223996. ［2］ Kong DQ, Su GQ, Zha L, et al. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer［J］. Med Oncol, 2014, 31(8): 130139. DOI:10.1007/s1203201401305. ［3］ Wang XC, Liu XY, Li AY, et al. Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers［J］. Clin Cancer Res, 2011, 17(8): 25702580. DOI:10.1158/10780432.CCR102542. ［4］ Wu Y, Song Y, Liu H. Expression and its clinical significance of HMGA2 in the patients with nonsmall cell lung cancer［J］. Zhongguo Fei Ai Za Zhi, 2008, 11(3): 377381. DOI:10.3779/j.issn.10093419.2008.03.005. ［5］ Di Cello F, Hillion J, Hristov A, et al. HMGA2 participates in transformation in human lung cancer［J］. Mol Cancer Res, 2008, 6(5): 743750. DOI:10.1158/15417786.MCR070095. ［6］ Kumar MS, ArmenterosMonterroso E, East P, et al. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression［J］. Nature, 2014, 505(7482): 212217. DOI:10.1038/nature12785. ［7］ Califano D, Pignata S, Losito NS, et al. High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer［J］. J Cell Physiol, 2014, 229(1): 5359. DOI:10.1002/jcp.24416. ［8］ Malek A, Bakhidze E, Noske A, et al. HMGA2 gene is a promising target for ovarian cancer silencing therapy［J］. Int J Cancer, 2008, 123(2): 348356. DOI:10.1002/ijc.23491. ［9］ Morishita A, Zaidi MR, Mitoro AA, et al. HMGA2 is a driver of tumor metastasis［J］. Cancer Res, 2013, 73(14): 42894299. DOI:10.1158/00085472.CAN123848. ［10］ Sun M, Song CX, Huang H, et al. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis［J］. Proc Natl Acad Sci USA, 2013, 110(24): 99209925. DOI:10.1073/pnas.1305172110. ［11］ Yang GL, Zhang LH, Bo JJ, et al. Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis［J］. Eur J Surg Oncol, 2011, 37(3): 265271. ［12］ Liu B, Pang B, Hou XZ, et al. Expression of highmobility group AThook protein 2 and its prognostic significance in malignant gliomas［J］. Hum Pathol, 2014, 45(8): 17521758. DOI:10.1016/j.humpath.2014.02.028. ［13］ Yamazaki H, Mori T, Yazawa M, et al. Stem cell selfrenewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis［J］. Lab Invest, 2013, 93(12): 13311338. DOI:10.1038/labinvest.2013.120. ［14］ Thuault S, Tan EJ, Peinado H, et al. HMGA2 and smads coregulate SNAIL1 expression during induction of EpithelialtoMesenchymal transition［J］. J Biol Chem, 2008, 283(48): 3343733446. DOI:10.1074/jbc.M802016200. ［15］ Li Y, Zhao ZX, Xu CH, et al. HMGA2 induces transcription factor Slug expression to promote epithelialtomesenchymal transition and contributes to colon cancer progression［J］. Cancer Lett, 2014, 355(1): 130140. DOI:10.1016/j.canlet.2014.09.007. ［16］ Ikeda K, Ogawa K, Takeishi Y. The role of HMGA2 in the proliferation and expansion of a hematopoietic cell in myeloproliferative neoplasms［J］. Fukushima J Med Sci, 2012, 58(2): 91100. ［17］ Morshedi A, Ren ZL, Li JM, et al. Probing into the biological processes influenced by ESC factor and oncoprotein HMGA2 using iPSCs［J］. Stem Cell Rev, 2013, 9(4): 514522. DOI:10.1007/s1201501293738. ［18］ Nishino J, Kim I, Chada K, et al. Hmga2 promotes neural stem cell selfrenewal in young but not old mice by reducing p16Ink4a and p19Arf expression［J］. Cell, 2008, 135(2): 227239. DOI:10.1016/j.cell.2008.09.017. ［19］ Fedele M, Visone R, De Martino I, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity［J］. Cancer Cell, 2006, 9(6): 459471. DOI:10.1016/j.ccr.2006.04.024. ［20］ De Martino I, Visone R, Wierinckx A, et al. HMGA proteins upregulate CCNB2 gene in mouse and human pituitary adenomas［J］. Cancer Res, 2009, 69(5): 18441850. DOI:10.1158/00085472.CAN084133. ［21］ Tessari MA, Gostissa M, Altamura S, et al. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2［J］. Mol Cell Biol, 2003, 23(24): 91049116. DOI:10.1128/MCB.23.24.91049116.2003. ［22］ Yu HJ, Lim HH, Tjokro NO, et al. Chaperoning HMGA2 protein protects stalled replication forks in stem and cancer cells［J］. Cell Rep, 2014, 6(4): 684697. DOI:10.1016/j.celrep.2014.01.014. ［23］ Li AY, Boo LM, Wang SY, et al. Suppression of nonhomologous end joining repair by overexpression of HMGA2［J］. Cancer Res, 2009, 69(14): 56995706. DOI:10.1158/00085472.CAN084833. ［24］ Borrmann L, Schwanbeck R, Heyduk T, et al. High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity［J］. Nucleic Acids Res, 2003, 31(23): 68416851. DOI:10.1093/nar/gkg884. ［25］ Natarajan S, HombachKlonisch S, Droege PA. HMGA2 inhibits apoptosis through interaction with ATRCHK1 signaling complex in human cancer cells［J］. Neoplasia, 2013, 15(3): 263. DOI:10.1593/neo.121988.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Expression and functional mechanism of high mobility group A2 in neoplasm

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments